Genetic clues may predict when Friedreich's ataxia begins
NCT ID NCT04346238
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 120 people with Friedreich's ataxia, a rare genetic disease that causes progressive movement problems. Researchers examined tiny interruptions in the DNA expansion that causes the disease to see if they influence when symptoms start and how severe they become. The goal is to better understand the disease, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRIEDREICH ATAXIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Uh Montpellier
Montpellier, Montpellier, 34295, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can voice and hearing tests reveal hidden clues to Friedreich's ataxia progression?
- Can advanced heart scans predict the biggest killer in Friedreich's ataxia?
- Video games and AI join the fight against a rare movement disorder
- Can a single gene fix a fatal heart condition? a trial aims to find out
- Brain function in Friedreich's ataxia: new clues from genetic testing
- Pregnancy safety of friedreich ataxia drug under scrutiny